Abstract
Hepatocellular carcinoma shows a rising incidence worldwide, and the largest burden of disease in Western countries derives from patients with alcoholic liver disease (ALD) and cirrhosis, the latter being the premier premalignant factor for HCC. The present chapter addresses key issues including the epidemiology of alcohol-associated HCC, and its link to other coexisting non-alcoholic liver diseases, and additional host and environmental risk factors including the underlying genetics. Also discussed are molecular mechanisms of alcohol-associated liver cancer evolution involving the mediators of alcohol toxicity and carcinogenicity, acetaldehyde and reactive oxygen species, as well as the recently described mutagenic adducts which these mediators form with DNA. Specifically, interference of alcohol with retinoids and cofactors of transmethylation processes are outlined. Information presented in this chapter illustrates that the development of HCC in the context of ALD is multifaceted and suggests several molecular targets for prevention and markers for the screening of risk groups.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Nordenstedt H, White DL, El-Serag HB (2010) The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 42(Suppl 3):S206–S214
Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127(5 Suppl 1):S35–S50
McGlynn KA, London WT (2011) The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 15:223–243
WHO. Mortality database. http://www.who.int/whosis/en
El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264–1273
Stickel F, Schuppan D, Hahn EG, Seitz HK (2002) Cocarcinogenic effects of ethanol in hepatocarcinogenesis. Gut 51:132–139
Ascha MS, Hanouneh IA, Lopez R et al (2010) The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51:1972–1978
Seitz HK, Stickel F (2007) Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7:599–612
Baan R, Straif K, Grosse Y et al (2007) Carcinogenicity of alcoholic beverages. Lancet Oncol 8:292–293
Rehm J, Klotsche J, Patra J (2007) Comparative quantification of alcohol exposure as risk factor for global burden of disease. Int J Methods Psychiatr Res 16:66–76
El-Serag HB, Davila JA, Petersen NJ, McGlynn KA (2003) The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139:817–823
Parkin DM (2002) Cancer incidence in five continents, vol VIII, IARC scientific publications. IARC, Lyon
El-Serag HB, Rudolph KL (2011) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576
El-Serag HB, Mason AC (2000) Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 160:3227–3230
Nzeako UC, Goodman ZD, Ishak KG (1996) Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. Am J Clin Pathol 105:65–75
Chiesa R, Donato F, Tagger A et al (2000) Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis. Cancer Epidemiol Biomarkers Prev 9:213–216
Grando-Lemaire V, Guettier C, Chevret S et al (1999) Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d’Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol 31:508–513
De Lima VM, Oliveira CP, Alves VA et al (2008) A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma. J Hepatol 49:1055–1061
Nakanuma Y, Ohta G (1985) Is Mallory body formation a preneoplastic change? A study of 181 cases of liver bearing hepatocellular carcinoma and 82 cases of cirrhosis. Cancer 55:2400–2405
Smith P, Tee LBG, Yeoh GCT (1996) Appearance of oval cells in the liver of rats after long-term exposure to ethanol. Hepatology 23:145–154
Lin RS, Lee FY, Lee SD et al (1995) Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 22:165–172
Yan AW, Fouts DE, Brandl J et al (2011) Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 53:96–105
Tilg H, Moschen AR, Kaneider NC (2011) Pathways of liver injury in alcoholic liver disease. J Hepatol 55(5):1159–1161
Yamada Y, Kirillova I, Peschon JJ et al (1997) Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 94:1441–1446
Bharrhan S, Koul A, Chopra K, Rishi P (2011) Catechin suppresses an array of signalling molecules and modulates alcohol-induced endotoxin mediated liver injury in a rat model. PLoS One 6:e20635
Stärkel P, De Saeger C, Strain AJ et al (2010) NFkappaB, cytokines, TLR 3 and 7 expression in human end-stage HCV and alcoholic liver disease. Eur J Clin Invest 40:575–584
Qiao L, Zhang H, Yu J et al (2006) Constitutive activation of NF-kappaB in human hepatocellular carcinoma: evidence of a cytoprotective role. Hum Gene Ther 17:280–290
Siu L, Foont J, Wands JR (2009) Hepatitis C virus and alcohol. Semin Liver Dis 29:188–199
Kowdley KV (2004) Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 127:S79–S86
Marcellin P, Pequignot F, Delarocque-Astagneau E et al (2008) Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol 48:200–207
Welzel TM, Graubard BI, Quraishi S et al (2013) Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol 108:1314–1321
Donato F, Tagger A, Gelatti U et al (2002) Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 155:323–331
Bedogni G, Miglioli L, Masutti F et al (2008) Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study. Am J Gastroenterol 103:2248–2253
Chen CL, Yang HI, Yang WS et al (2008) Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 135:111–121
Jee SH, Ohrr H, Sull JW, Samet JM (2004) Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 96:1851–1855
Lambert MP, Paliwal A, Vaissière T et al (2011) Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol 54:705–715
Miyakawa H, Izumi N, Marumo F, Sato C (1996) Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis. Alcohol Clin Exp Res 20(1 Suppl):91A–94A
Peters MG, Terrault NA (2002) Alcohol use and hepatitis C. Hepatology 36(5 Suppl 1):S220–S225
Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB (2004) Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127:1372–1380
Bellentani S, Pozzato G, Saccoccio G et al (1999) Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut 44:874–880
Hassan MM, Hwang LY, Hatten CJ et al (2002) Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36:1206–1213
Uetake S, Yamauchi M, Itoh S et al (2003) Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Alcohol Clin Exp Res 27(8 Suppl):47S–51S
Donato F, Gelatti U, Limina RM, Fattovich G (2006) Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence. Oncogene 25:3756–3770
Moriya K, Fujie H, Shintani Y et al (1998) Hepatitis C virus core protein induces hepatocellular carcinoma in transgenic mice. Nat Med 4:1065–1068
Koike K (2007) Hepatitis C, virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. J Gastroenterol Hepatol 22(Suppl 1):S108–S111
Hoek JB, Pastorino JG (2004) Cellular signaling mechanisms in alcohol-induced liver damage. Semin Liver Dis 24:257–272
Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC (1997) Excess weight is a risk factor for alcoholic liver disease. Hepatology 25:108–111
Raynard B, Balian A, Fallik D et al (2002) Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 35:635–638
Ekstedt M, Franzén LE, Holmqvist M et al (2009) Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scand J Gastroenterol 44:366–374
Dunn W, Sanyal AJ, Brunt EM et al (2012) Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J Hepatol 57:384–391
Moriya A, Iwasaki Y, Ohguchi S et al (2011) Alcohol consumption appears to protect against non-alcoholic fatty liver disease. Aliment Pharmacol Ther 33:378–388
Craddock VM, Henderson AR (1991) Potent inhibition of oesophageal metabolism of N-nitrosomethylbenzylamine, an oesophageal carcinogen, by higher alcohols present in alcoholic beverages. IARC Sci Publ 564–567
Kuper H, Tzonou A, Kaklamani E et al (2000) Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 85:498–502
Seitz HK, Osswald B (1992) Effect of ethanol on procarcinogen activation. In: Watson R (ed) Alcohol and cancer. CRC, Boca Raton, pp 55–72
Aguilar F, Hussain SP, Cerutti P (1993) Aflatoxin B1 induces the transversion of G -> T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci U S A 90:8586–8590
Bulatao-Jayme J, Almero EM, Castro MC, Jardeleza MT, Salamat LA (1982) A case-control dietary study of primary liver cancer risk from aflatoxin exposure. Int J Epidemiol 11:112–119
National Toxicology Program (2011) Acetaldehyde. Rep Carcinog 12:21–24
Helander A, Lindahl-Kiessling K (1991) Increased frequency of acetaldehyde-induced sister-chromatid exchanges in human lymphocytes treated with an aldehyde dehydrogenase inhibitor. Mutat Res 264:103–107
Maffei F, Fimognari C, Castelli E et al (2000) Increased cytogenetic damage detected by FISH analysis on micronuclei in peripheral lymphocytes from alcoholics. Mutagenesis 15:517–523
Maffei F, Forti GC, Castelli E, Stefanini GF, Mattioli S, Hrelia P (2002) Biomarkers to assess the genetic damage induced by alcohol abuse in human lymphocytes. Mutat Res 514:49–58
Matsuda T, Kawanishi M, Yagi T et al (1998) Specific tandem GG to TT base substitutions induced by acetaldehyde are due to intra-strand crosslinks between adjacent guanine bases. Nucleic Acids Res 26:1769–1774
Garro AJ, Espina N, Farinati F, Salvagnini M (1986) The effects of chronic ethanol consumption on carcinogen metabolism and on O6-methylguanine transferase-mediated repair of alkylated DNA. Alcohol Clin Exp Res 10:73S–77S
Theruvathu JA, Jaruga P, Nath RG, Dizdaroglu M, Brooks PJ (2005) Polyamines stimulate the formation of mutagenic 1, N2-propanodeoxyguanosine adducts from acetaldehyde. Nucleic Acids Res 33:3513–3520
Fang JL, Vaca CE (1995) Development of a 32P-postlabelling method for the analysis of adducts arising through the reaction of acetaldehyde with 2'-deoxyguanosine-3'-monophosphate and DNA. Carcinogenesis 16:2177–2185
Fang JL, Vaca CE (1997) Detection of DNA adducts of acetaldehyde in peripheral white blood cells of alcohol abusers. Carcinogenesis 18:627–632
Matsuda T, Matsumoto A, Uchida M et al (2007) Increased formation of hepatic N2-ethylidene-2′-deoxyguanosine DNA adducts in aldehyde dehydrogenase 2-knockout mice treated with ethanol. Carcinogenesis 28:2363–2366
Wang M, McIntee EJ, Cheng G, Shi Y, Villalta PW, Hecht SS (2000) Identification of DNA adducts of acetaldehyde. Chem Res Toxicol 13:1149–1157
Wang M, Yu N, Chen L, Villalta PW, Hochalter JB, Hecht SS (2006) Identification of an acetaldehyde adduct in human liver DNA and quantitation as N2-ethyldeoxyguanosine. Chem Res Toxicol 19:319–324
Stein S, Lao Y, Yang IY, Hecht SS, Moriya M (2006) Genotoxicity of acetaldehyde- and crotonaldehyde-induced 1, N2-propanodeoxyguanosine DNA adducts in human cells. Mutat Res 608:1–7
Yokoyama A, Muramatsu T, Ohmori T et al (1998) Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 19:1383–1387
Homann N, Stickel F, Konig IR, Jacobs A, Junghanns K, Benesova M, Schuppan D, Himsel S, Zuber-Jerger I, Hellerbrand C, Ludwig D, Caselmann WH et al (2006) Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkers. Int J Cancer 118:1998–2002
Albano E (2002) Free radical mechanisms in immune reactions associated with alcoholic liver disease. Free Radic Biol Med 32:110–114
Garcia-Ruiz C, Colell A, Paris R, Fernandez-Checa JC (2000) Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation. FASEB J 14:847–858
Bautista AP (2002) Neutrophilic infiltration in alcoholic hepatitis. Alcohol 27:17–21
Chamulitrat W, Spitzer JJ (1996) Nitric oxide and liver injury in alcohol-fed rats after lipopolysaccharide administration. Alcohol Clin Exp Res 20:1065–1070
Oneta CM, Lieber CS, Li J, Ruttimann S, Schmid B, Lattmann J, Rosman AS, Seitz HK (2002) Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. J Hepatol 36:47–52
Gouillon Z, Lucas D, Li J, Hagbjork AL, French BA, Fu P, Fang C, Ingelman-Sundberg M, Donohue TM Jr, French SW (2000) Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc Soc Exp Biol Med 224:302–308
Bradford BU, Kono H, Isayama F et al (2005) Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology 41:336–344
Morgan K, French SW, Morgan TR (2002) Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 36:122–134
Frank A, Seitz HK, Bartsch H, Frank N, Nair J (2004) Immunohistochemical detection of 1, N6-ethenodeoxyadenosine in nuclei of human liver affected by diseases predisposing to hepato-carcinogenesis. Carcinogenesis 25:1027–1031
Fernando RC, Nair J, Barbin A, Miller JA, Bartsch H (1996) Detection of 1, N6-ethenodeoxyadenosine and 3, N4-ethenodeoxycytidine by immunoaffinity/32 P-postlabelling in liver and lung DNA of mice treated with ethyl carbamate (urethane) or its metabolites. Carcinogenesis 17:1711–1718
Wang Y, Millonig G, Nair J et al (2009) Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease. Hepatology 50:453–461
Nair J, Srivatanakul P, Haas C, Jedpiyawongse A, Khuhaprema T, Seitz HK, Bartsch H (2010) High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases. Mutat Res 683:23–28
Mandrekar P (2011) Epigenetic regulation in alcoholic liver disease. World J Gastroenterol 17:2456–2464
Stickel F, Herold C, Seitz HK, Schuppan D (2006) Alcohol and methyl transfer: Implication for alcohol related hepatocarcinogenesis. In: Ali S, Friedman SL, Mann DA (eds) Liver disease: biochemical mechanisms and new therapeutic insights. Science Publisher Enfield, Plymouth, pp 45–58
Leo MA, Lieber CS (1982) Hepatic vitamin A depletion in alcoholic liver injury. N Engl J Med 307:597–601
Wang XD, Liu C, Chung J et al (1998) Chronic alcohol intake reduces retinoic acid concentration and enhances AP-1 (c-Jun and c-Fos) expression in rat liver. Hepatology 28:744–750
Liu C, Russell RM, Seitz HK, Wang XD (2001) Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1. Gastroenterology 120:179–189
Dan Z, Popov Y, Patsenker E, Preimel D, Liu C, Wang XD, Seitz HK, Schuppan D, Stickel F (2005) Hepatotoxicity of alcohol-induced polar retinol metabolites involves apoptosis via loss of mitochondrial membrane potential. FASEB J 19:845–847
Albanes D, Heinonen OP, Taylor PR et al (1996) Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 88:1560–1570
Nahon P, Sutton A, Rufat P et al (2009) Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis. Hepatology 50:1484–1493
Stickel F, Hampe J (2012) Genetic determinants of alcoholic liver disease. Gut 61:150–159
Trépo E, Nahon P, Bontempi G et al (2014) Association between the PNPLA3 (rs738409 C > G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data. Hepatology 59(6):2170–2177. doi:10.1002/hep.26767
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this paper
Cite this paper
Stickel, F. (2015). Alcoholic Cirrhosis and Hepatocellular Carcinoma. In: Vasiliou, V., Zakhari, S., Seitz, H., Hoek, J. (eds) Biological Basis of Alcohol-Induced Cancer. Advances in Experimental Medicine and Biology, vol 815. Springer, Cham. https://doi.org/10.1007/978-3-319-09614-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-09614-8_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09613-1
Online ISBN: 978-3-319-09614-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)